Yang-Hee Kim

Yang-Hee Kim is a Professor in the Department of Integrative Bioscience and Biotechnology at Sejong University, South Korea, with a distinguished research career focusing on neuroscience and neurodegenerative diseases. Previously, they served as Associate Professor (2008-2015) and Assistant Professor (2004-2008) in related departments at Sejong University, and held a visiting professorship at Sanford-Burnham Medical Research Institute (2009-2010).

Dr. Kim's educational background includes:

• Ph.D. from Seoul National University (2000)
• M.S. from Seoul National University (1995)
• B.S. from Yonsei University (1992)

Research interests center on the role of zinc in neurological disorders:

• Mechanisms of zinc-mediated neurotoxicity in acute brain injury
• Zinc-induced enhancement of autophagic flux and lysosomal function
• Development of novel therapeutics for stroke and neurodegenerative conditions

Dr. Kim's research has significantly advanced understanding of zinc neurotoxicity, lysosomal function in neurodegeneration, and therapeutic development for conditions like stroke and ALS. With an h-index of 25 and over 1,977 citations, their work demonstrates substantial impact in the neuroscience field. Recent publications (2022-2024) continue to explore zinc biology, lysosomal function, and potential therapeutic applications.

Dr. Kim currently serves as CTO of Zincure Corp (2020-present), translating research findings into clinical applications for neurological disorders.